IL-29/IFN-lambda 1 Products

1598-IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepatocellular carcinoma cell line in a dose-dependent manner (orange line). Inhibition of EMCV activity elicited by Recombinant Human IL-29/IFN-lambda 1 (40 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anri-Human IL-29/IFN-lambda 1 Monoclonal Antibody (Catalog # MAB15981). The ND₅₀ is typically 1-4 µg/mL." class="big_lightbox" target="_blank">

1598-IL) was serially diluted and captured by Mouse Anti-Human IL‑29/IFN‑ lambda 1 Monoclonal Antibody (Catalog # MAB15981) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human IL‑29/IFN‑ lambda 1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1598) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox" target="_blank">

1598-IL) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the HepG2 human hepato-cellular carcinoma cell line in a dose-dependent manner (orange line), as measured by crystal violet staining. Inhibition of EMCV activity elicited by Recombinant Human IL-29/IFN-lambda 1 (40 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL-29/IFN-lambda 1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1598). The ND₅₀ is typically 0.2-1.0 µg/mL." class="big_lightbox" target="_blank">

1598-IL) was serially diluted and captured by Mouse Anti-Human IL‑29/IFN‑ lambda 1 Monoclonal Antibody (Catalog # MAB15981) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human IL‑29/IFN‑ lambda 1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1598) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox" target="_blank">